PMDA drug package insert
サーバリックス
PMDA Prescription drug · グラクソ・スミスクライン株式会社 · package insert May 19, 2026
Key facts
| Brand names | サーバリックス |
|---|---|
| Nonproprietary names | 組換え沈降２価ヒトパピローマウイルス様粒子ワクチン |
| Companies | 製造販売元／グラクソ・スミスクライン株式会社 |
| Product type | Prescription drug |
| Therapeutic category | ウイルスワクチン類 |
| Therapeutic category codes | 876313 |
| YJ codes | 631340QG1022 |
| Approval numbers | 22100AMX02268 |
| Package insert edition | 第2版 |
| Package insert date | May 19, 2026 |
| PMDA document key | 340278_631340QG1022_2 |
| PMDA company code | 340278 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: